Top Markets
Coin of the day
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Kedudukan dalam Saham #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in MalmΓΆ, Sweden.
Harga Saham
$0.00162013
Disegerakkan terakhir: 2025-01-03
Modal Pasaran
$156.25K
Perubahan (1 hari)
0.36%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Cyxone AB (publ) (CYXO)

Kategori

Sejarah pecahan saham untuk Cyxone AB (publ) (CYXO)
Saham Cyxone AB (publ) (simbol: CYXO) telah mengalami sejumlah 2 pecahan saham.
Pecahan saham terkini berlaku pada Dec 28, 2021.
Satu saham CYXO yang dibeli sebelum Oct 03, 2018 kini bersamaan dengan 1.12682 saham CYXO.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2021-12-28 103:100 x1.03 x1.12682
2018-10-03 547:500 x1.094 x1.094
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE